Heartflow, Inc. (HTFL) Financial Statements
Industry: Surgical & Medical Instruments & Apparatus
In fiscal 2025, Heartflow reported revenue of $176.0M. Net income was -$116.8M (a -66.3% net margin), or -$3.17 per diluted share. Gross margin was 76.8% and operating margin was -36.4%. Operating activities generated -$54.0M of cash, leaving -$59.0M of free cash flow. At fiscal year end, Heartflow held $359.5M in total assets against $58.8M in total liabilities, including $44.8M of cash and equivalents.
Open the full interactive Heartflow financials → Quarterly statements, key ratios, valuation history and price charts.
Heartflow Key Stats
| Share Price | $50.32 |
|---|---|
| Market Cap | $4.35B |
| 52-Week Range | $20.49 – $52.21 |
| Shares Outstanding | 86.4 million (basic, 2026 Q2) |
Heartflow Income Statement
| FY 2025 | |
|---|---|
| Revenue | $176.0M |
| Gross Profit | $135.2M |
| Operating Income | -$64.1M |
| Pre-Tax Income | -$116.9M |
| Income Tax | -$76,000 |
| Net Income | -$116.8M |
| Diluted EPS | -$3.17 |
Heartflow Quarterly Results
| 2025 Q2 | 2025 Q3 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $43.4M | $46.3M | $52.6M | $64.1M |
| Net Income | -$9.2M | -$50.9M | -$27.4M | -$15.7M |
| Diluted EPS | -$1.46 | -$1.04 | -$0.32 | -$0.18 |
Heartflow Balance Sheet
| FY 2025 | |
|---|---|
| Cash & Equivalents | $44.8M |
| Current Assets | $220.2M |
| Total Assets | $359.5M |
| Current Liabilities | $42.4M |
| Total Liabilities | $58.8M |
| Shareholders' Equity | $300.6M |
Heartflow Cash Flow Statement
| FY 2025 | |
|---|---|
| Cash From Operations | -$54.0M |
| Cash From Investing | -$238.6M |
| Cash From Financing | $286.0M |
| Free Cash Flow | -$59.0M |
Figures from Heartflow's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Heartflow financials page for every line item.
Heartflow Company Profile
| Ticker | HTFL |
|---|---|
| Exchange | Nasdaq |
| Industry | Surgical & Medical Instruments & Apparatus |
| Headquarters | San Francisco, California |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Non-accelerated filer, emerging growth company |
| SEC CIK | 0001464521 |
Frequently Asked Questions
What was Heartflow's revenue in fiscal 2025?
Heartflow (HTFL) reported revenue of $176.0M for fiscal 2025.
What was Heartflow's net income in fiscal 2025?
Heartflow reported net income of -$116.8M for fiscal 2025.
What was Heartflow's earnings per share (EPS) in fiscal 2025?
Heartflow's diluted EPS was -$3.17 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Heartflow generate in fiscal 2025?
Heartflow generated -$59.0M of free cash flow in fiscal 2025.
What was Heartflow's revenue last quarter?
In its most recent reported quarter (2026 Q2), Heartflow reported revenue of $64.1M.
How many shares of Heartflow are outstanding?
Heartflow reported a weighted average of 86.4 million basic shares outstanding in 2026 Q2.
What is Heartflow's market cap?
Based on its latest closing price, Heartflow (HTFL) has a market capitalization of about $4.35B.
When does Heartflow's fiscal year end?
Heartflow's fiscal year end, as registered with the SEC, is December 31.
Where is Heartflow headquartered?
Heartflow lists its business address in San Francisco, California in its SEC filings.